Ovarian cancer risk factors by tumor aggressiveness: An analysis from the Ovarian Cancer Cohort Consortium
Ovarian cancer risk factors differ by histotype; however, within subtype, there is substantial variability in outcomes. We hypothesized that risk factor profiles may influence tumor aggressiveness, defined by time between diagnosis and death, independent of histology. Among 1.3 million women from 21...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Wiley
2019
|
| _version_ | 1826301433848266752 |
|---|---|
| author | Fortner, RT Poole, EM Wentzensen, NA Trabert, B White, E Arslan, AA Patel, AV Setiawan, VW Visvanathan, K Weiderpass, E Adami, H-O Black, A Bernstein, L Brinton, LA Buring, J Clendenen, TV Fournier, A Fraser, G Gapstur, SM Gaudet, MM Giles, GG Gram, IT Hartge, P Hoffman-Bolton, J Idahl, A Kaaks, R Kirsh, VA Knutsen, S Koh, W-P Lacey, JV Lee, I-M Lundin, E Merritt, MA Milne, RL Onland-Moret, NC Peters, U Poynter, JN Rinaldi, S Robien, K Rohan, T Sánchez, M-J Schairer, C Schouten, LJ Tjonneland, A Townsend, MK Travis, RC Trichopoulou, A Van Den Brandt, PA Vineis, P Wilkens, L Wolk, A Yang, HP Zeleniuch-Jacquotte, A Tworoger, SS |
| author_facet | Fortner, RT Poole, EM Wentzensen, NA Trabert, B White, E Arslan, AA Patel, AV Setiawan, VW Visvanathan, K Weiderpass, E Adami, H-O Black, A Bernstein, L Brinton, LA Buring, J Clendenen, TV Fournier, A Fraser, G Gapstur, SM Gaudet, MM Giles, GG Gram, IT Hartge, P Hoffman-Bolton, J Idahl, A Kaaks, R Kirsh, VA Knutsen, S Koh, W-P Lacey, JV Lee, I-M Lundin, E Merritt, MA Milne, RL Onland-Moret, NC Peters, U Poynter, JN Rinaldi, S Robien, K Rohan, T Sánchez, M-J Schairer, C Schouten, LJ Tjonneland, A Townsend, MK Travis, RC Trichopoulou, A Van Den Brandt, PA Vineis, P Wilkens, L Wolk, A Yang, HP Zeleniuch-Jacquotte, A Tworoger, SS |
| author_sort | Fortner, RT |
| collection | OXFORD |
| description | Ovarian cancer risk factors differ by histotype; however, within subtype, there is substantial variability in outcomes. We hypothesized that risk factor profiles may influence tumor aggressiveness, defined by time between diagnosis and death, independent of histology. Among 1.3 million women from 21 prospective cohorts, 4,584 invasive epithelial ovarian cancers were identified and classified as highly aggressive (death in <1 year, n = 864), very aggressive (death in 1 to < 3 years, n = 1,390), moderately aggressive (death in 3 to < 5 years, n = 639), and less aggressive (lived 5+ years, n = 1,691). Using competing risks Cox proportional hazards regression, we assessed heterogeneity of associations by tumor aggressiveness for all cases and among serous and endometrioid/clear cell tumors. Associations between parity (phet = 0.01), family history of ovarian cancer (phet = 0.02), body mass index (BMI; phet ≤ 0.04) and smoking (phet < 0.01) and ovarian cancer risk differed by aggressiveness. A first/single pregnancy, relative to nulliparity, was inversely associated with highly aggressive disease (HR: 0.72; 95% CI [0.58-0.88]), no association was observed for subsequent pregnancies (per pregnancy, 0.97 [0.92-1.02]). In contrast, first and subsequent pregnancies were similarly associated with less aggressive disease (0.87 for both). Family history of ovarian cancer was only associated with risk of less aggressive disease (1.94 [1.47-2.55]). High BMI (≥35 vs. 20 to < 25 kg/m2 , 1.93 [1.46-2.56] and current smoking (vs. never, 1.30 [1.07-1.57]) were associated with increased risk of highly aggressive disease. Results were similar within histotypes. Ovarian cancer risk factors may be directly associated with subtypes defined by tumor aggressiveness, rather than through differential effects on histology. Studies to assess biological pathways are warranted. |
| first_indexed | 2024-03-07T05:32:22Z |
| format | Journal article |
| id | oxford-uuid:e2b34081-63b3-40cd-8229-c9fe553135be |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T05:32:22Z |
| publishDate | 2019 |
| publisher | Wiley |
| record_format | dspace |
| spelling | oxford-uuid:e2b34081-63b3-40cd-8229-c9fe553135be2022-03-27T10:03:48ZOvarian cancer risk factors by tumor aggressiveness: An analysis from the Ovarian Cancer Cohort ConsortiumJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:e2b34081-63b3-40cd-8229-c9fe553135beEnglishSymplectic Elements at OxfordWiley2019Fortner, RTPoole, EMWentzensen, NATrabert, BWhite, EArslan, AAPatel, AVSetiawan, VWVisvanathan, KWeiderpass, EAdami, H-OBlack, ABernstein, LBrinton, LABuring, JClendenen, TVFournier, AFraser, GGapstur, SMGaudet, MMGiles, GGGram, ITHartge, PHoffman-Bolton, JIdahl, AKaaks, RKirsh, VAKnutsen, SKoh, W-PLacey, JVLee, I-MLundin, EMerritt, MAMilne, RLOnland-Moret, NCPeters, UPoynter, JNRinaldi, SRobien, KRohan, TSánchez, M-JSchairer, CSchouten, LJTjonneland, ATownsend, MKTravis, RCTrichopoulou, AVan Den Brandt, PAVineis, PWilkens, LWolk, AYang, HPZeleniuch-Jacquotte, ATworoger, SSOvarian cancer risk factors differ by histotype; however, within subtype, there is substantial variability in outcomes. We hypothesized that risk factor profiles may influence tumor aggressiveness, defined by time between diagnosis and death, independent of histology. Among 1.3 million women from 21 prospective cohorts, 4,584 invasive epithelial ovarian cancers were identified and classified as highly aggressive (death in <1 year, n = 864), very aggressive (death in 1 to < 3 years, n = 1,390), moderately aggressive (death in 3 to < 5 years, n = 639), and less aggressive (lived 5+ years, n = 1,691). Using competing risks Cox proportional hazards regression, we assessed heterogeneity of associations by tumor aggressiveness for all cases and among serous and endometrioid/clear cell tumors. Associations between parity (phet = 0.01), family history of ovarian cancer (phet = 0.02), body mass index (BMI; phet ≤ 0.04) and smoking (phet < 0.01) and ovarian cancer risk differed by aggressiveness. A first/single pregnancy, relative to nulliparity, was inversely associated with highly aggressive disease (HR: 0.72; 95% CI [0.58-0.88]), no association was observed for subsequent pregnancies (per pregnancy, 0.97 [0.92-1.02]). In contrast, first and subsequent pregnancies were similarly associated with less aggressive disease (0.87 for both). Family history of ovarian cancer was only associated with risk of less aggressive disease (1.94 [1.47-2.55]). High BMI (≥35 vs. 20 to < 25 kg/m2 , 1.93 [1.46-2.56] and current smoking (vs. never, 1.30 [1.07-1.57]) were associated with increased risk of highly aggressive disease. Results were similar within histotypes. Ovarian cancer risk factors may be directly associated with subtypes defined by tumor aggressiveness, rather than through differential effects on histology. Studies to assess biological pathways are warranted. |
| spellingShingle | Fortner, RT Poole, EM Wentzensen, NA Trabert, B White, E Arslan, AA Patel, AV Setiawan, VW Visvanathan, K Weiderpass, E Adami, H-O Black, A Bernstein, L Brinton, LA Buring, J Clendenen, TV Fournier, A Fraser, G Gapstur, SM Gaudet, MM Giles, GG Gram, IT Hartge, P Hoffman-Bolton, J Idahl, A Kaaks, R Kirsh, VA Knutsen, S Koh, W-P Lacey, JV Lee, I-M Lundin, E Merritt, MA Milne, RL Onland-Moret, NC Peters, U Poynter, JN Rinaldi, S Robien, K Rohan, T Sánchez, M-J Schairer, C Schouten, LJ Tjonneland, A Townsend, MK Travis, RC Trichopoulou, A Van Den Brandt, PA Vineis, P Wilkens, L Wolk, A Yang, HP Zeleniuch-Jacquotte, A Tworoger, SS Ovarian cancer risk factors by tumor aggressiveness: An analysis from the Ovarian Cancer Cohort Consortium |
| title | Ovarian cancer risk factors by tumor aggressiveness: An analysis from the Ovarian Cancer Cohort Consortium |
| title_full | Ovarian cancer risk factors by tumor aggressiveness: An analysis from the Ovarian Cancer Cohort Consortium |
| title_fullStr | Ovarian cancer risk factors by tumor aggressiveness: An analysis from the Ovarian Cancer Cohort Consortium |
| title_full_unstemmed | Ovarian cancer risk factors by tumor aggressiveness: An analysis from the Ovarian Cancer Cohort Consortium |
| title_short | Ovarian cancer risk factors by tumor aggressiveness: An analysis from the Ovarian Cancer Cohort Consortium |
| title_sort | ovarian cancer risk factors by tumor aggressiveness an analysis from the ovarian cancer cohort consortium |
| work_keys_str_mv | AT fortnerrt ovariancancerriskfactorsbytumoraggressivenessananalysisfromtheovariancancercohortconsortium AT pooleem ovariancancerriskfactorsbytumoraggressivenessananalysisfromtheovariancancercohortconsortium AT wentzensenna ovariancancerriskfactorsbytumoraggressivenessananalysisfromtheovariancancercohortconsortium AT trabertb ovariancancerriskfactorsbytumoraggressivenessananalysisfromtheovariancancercohortconsortium AT whitee ovariancancerriskfactorsbytumoraggressivenessananalysisfromtheovariancancercohortconsortium AT arslanaa ovariancancerriskfactorsbytumoraggressivenessananalysisfromtheovariancancercohortconsortium AT patelav ovariancancerriskfactorsbytumoraggressivenessananalysisfromtheovariancancercohortconsortium AT setiawanvw ovariancancerriskfactorsbytumoraggressivenessananalysisfromtheovariancancercohortconsortium AT visvanathank ovariancancerriskfactorsbytumoraggressivenessananalysisfromtheovariancancercohortconsortium AT weiderpasse ovariancancerriskfactorsbytumoraggressivenessananalysisfromtheovariancancercohortconsortium AT adamiho ovariancancerriskfactorsbytumoraggressivenessananalysisfromtheovariancancercohortconsortium AT blacka ovariancancerriskfactorsbytumoraggressivenessananalysisfromtheovariancancercohortconsortium AT bernsteinl ovariancancerriskfactorsbytumoraggressivenessananalysisfromtheovariancancercohortconsortium AT brintonla ovariancancerriskfactorsbytumoraggressivenessananalysisfromtheovariancancercohortconsortium AT buringj ovariancancerriskfactorsbytumoraggressivenessananalysisfromtheovariancancercohortconsortium AT clendenentv ovariancancerriskfactorsbytumoraggressivenessananalysisfromtheovariancancercohortconsortium AT fourniera ovariancancerriskfactorsbytumoraggressivenessananalysisfromtheovariancancercohortconsortium AT fraserg ovariancancerriskfactorsbytumoraggressivenessananalysisfromtheovariancancercohortconsortium AT gapstursm ovariancancerriskfactorsbytumoraggressivenessananalysisfromtheovariancancercohortconsortium AT gaudetmm ovariancancerriskfactorsbytumoraggressivenessananalysisfromtheovariancancercohortconsortium AT gilesgg ovariancancerriskfactorsbytumoraggressivenessananalysisfromtheovariancancercohortconsortium AT gramit ovariancancerriskfactorsbytumoraggressivenessananalysisfromtheovariancancercohortconsortium AT hartgep ovariancancerriskfactorsbytumoraggressivenessananalysisfromtheovariancancercohortconsortium AT hoffmanboltonj ovariancancerriskfactorsbytumoraggressivenessananalysisfromtheovariancancercohortconsortium AT idahla ovariancancerriskfactorsbytumoraggressivenessananalysisfromtheovariancancercohortconsortium AT kaaksr ovariancancerriskfactorsbytumoraggressivenessananalysisfromtheovariancancercohortconsortium AT kirshva ovariancancerriskfactorsbytumoraggressivenessananalysisfromtheovariancancercohortconsortium AT knutsens ovariancancerriskfactorsbytumoraggressivenessananalysisfromtheovariancancercohortconsortium AT kohwp ovariancancerriskfactorsbytumoraggressivenessananalysisfromtheovariancancercohortconsortium AT laceyjv ovariancancerriskfactorsbytumoraggressivenessananalysisfromtheovariancancercohortconsortium AT leeim ovariancancerriskfactorsbytumoraggressivenessananalysisfromtheovariancancercohortconsortium AT lundine ovariancancerriskfactorsbytumoraggressivenessananalysisfromtheovariancancercohortconsortium AT merrittma ovariancancerriskfactorsbytumoraggressivenessananalysisfromtheovariancancercohortconsortium AT milnerl ovariancancerriskfactorsbytumoraggressivenessananalysisfromtheovariancancercohortconsortium AT onlandmoretnc ovariancancerriskfactorsbytumoraggressivenessananalysisfromtheovariancancercohortconsortium AT petersu ovariancancerriskfactorsbytumoraggressivenessananalysisfromtheovariancancercohortconsortium AT poynterjn ovariancancerriskfactorsbytumoraggressivenessananalysisfromtheovariancancercohortconsortium AT rinaldis ovariancancerriskfactorsbytumoraggressivenessananalysisfromtheovariancancercohortconsortium AT robienk ovariancancerriskfactorsbytumoraggressivenessananalysisfromtheovariancancercohortconsortium AT rohant ovariancancerriskfactorsbytumoraggressivenessananalysisfromtheovariancancercohortconsortium AT sanchezmj ovariancancerriskfactorsbytumoraggressivenessananalysisfromtheovariancancercohortconsortium AT schairerc ovariancancerriskfactorsbytumoraggressivenessananalysisfromtheovariancancercohortconsortium AT schoutenlj ovariancancerriskfactorsbytumoraggressivenessananalysisfromtheovariancancercohortconsortium AT tjonnelanda ovariancancerriskfactorsbytumoraggressivenessananalysisfromtheovariancancercohortconsortium AT townsendmk ovariancancerriskfactorsbytumoraggressivenessananalysisfromtheovariancancercohortconsortium AT travisrc ovariancancerriskfactorsbytumoraggressivenessananalysisfromtheovariancancercohortconsortium AT trichopouloua ovariancancerriskfactorsbytumoraggressivenessananalysisfromtheovariancancercohortconsortium AT vandenbrandtpa ovariancancerriskfactorsbytumoraggressivenessananalysisfromtheovariancancercohortconsortium AT vineisp ovariancancerriskfactorsbytumoraggressivenessananalysisfromtheovariancancercohortconsortium AT wilkensl ovariancancerriskfactorsbytumoraggressivenessananalysisfromtheovariancancercohortconsortium AT wolka ovariancancerriskfactorsbytumoraggressivenessananalysisfromtheovariancancercohortconsortium AT yanghp ovariancancerriskfactorsbytumoraggressivenessananalysisfromtheovariancancercohortconsortium AT zeleniuchjacquottea ovariancancerriskfactorsbytumoraggressivenessananalysisfromtheovariancancercohortconsortium AT tworogerss ovariancancerriskfactorsbytumoraggressivenessananalysisfromtheovariancancercohortconsortium |